UK approves Pfizer-BioNTech's bivalent COVID booster

Britain's medicines regulator on Wednesday approved an adapted COVID-19 vaccine from U.S. drugmaker Pfizer and German partner BioNTech as a booster.

The shot targets the original coronavirus as well as Omicron BA.4 and BA.5 sub-variants.